ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Early Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusion and Pleural Empyema

This study is currently recruiting participants.
Verified by University Hospital, Basel, Switzerland, October 2005

Sponsors and Collaborators: University Hospital, Basel, Switzerland
Lancardis foundation, Martigny Switzerland
Pfizer
Information provided by: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT00234208
  Purpose

Multicenter, randomized controlled study to compare early mini-invasive thoracoscopy to simple chest tube drainage in complicated parapneumonic effusions or pleural empyema. 100 patients will be recruited. Follow-up will be 3 months. It will be looked at the rate medical cure, the need for secondary interventions, death and duration of hospital stay. In a nested trial in 20 patients the intrapleural pharmacokinetics of linezolid (approved antibiotic agent) will be measured.


Condition Intervention Phase
Complicated Parapneumonic Effusion
Pleural Empyema
Procedure: Medical thoracoscopy
Procedure: Simple chest tube drainage
Phase III

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   A Randomized Controlled Study of Early Mini-Invasive Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusions or Pleural Empyema – ESMITE (European Study on Mini-Invasive Thoracoscopy in Empyema)

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Medical cure without secondary Intervention
  • Death

Secondary Outcome Measures:
  • Duration of hospital stay
  • Radiological outcome
  • Duration of drainage
  • Total amount of drainage fluid
  • Estimated cost
  • Adverse events
  • Pleural pharmacokinetics of linezolid

Estimated Enrollment:   100
Study Start Date:   October 2005
Estimated Study Completion Date:   October 2008

Detailed Description:

Background Pleural empyema has a high morbidity and mortality. Until now it is not clear which method is best to initially drain the pus, especially in complicated effusions with septa.

The objective of this study is to compare the standard treatment of simple chest tube drainage to early mini-invasive medical thoracoscopy. In earlier studies medical thoracoscopy has been a safe and effective method in pleural diseases. However there is no prospective data available.

Methods We conduct a prospective randomized controlled multicenter study on 100 patients with complicated parapneumonic effusions with septa or empyema with frank pus. Patients will be randomized to receive either simple chest tube drainage or early medical thoracoscopy. The latter will be performed in local anaesthesia and analgosedation according to the standards set by the European Study on Medical Video-Assisted Thoracoscopy (ESMEVAT)-group. Fibrinolysis will be used routinely. In 20 patients a nested study on the intrapleural pharmacokinetics of linezolid as antibiotic agent will be performed.

Follow-up will be structured on day 1, day 7, before discharge and after 3 months including chest radiographs and clinical and laboratory evaluations.

Outcome Primary outcome will be medical cure without the need of secondary intervention or death.

As secondary outcome we will measure duration of hospital stay, adverse events.

Provisional agenda Start of study: October 2005 End of study: October 2007

Potential outcome & benefit The study should clarify the role of early medical thoracoscopy in patients with complicated parapneumonic effusions or pleural empyema. Different authors have speculated that early intervention could be preferable. On the other hand, in many centres worldwide patients are primarily treated by a simple chest tube with or without pleural fibrinolysis. In case of failure of simple drainage, but this means several “precious” days later, a more invasive procedure is needed. At that moment tight pleural septa have formed, and often a surgical VATS or thoracotomy in general anaesthesia becomes necessary. Therefore, this pivotal study could lead to changes in the management of patients with pleural empyema.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Septated pleural effusion (ultrasonography) in the context of a lower respiratory tract infection
  • Frank pleural empyema (pus)

Exclusion Criteria:

  • Fibrothorax
  • Tuberculous empyema
  • Medical thoracoscopy cannot be performed within 24 hours
  • Pregnancy
  • Inability to give informed consent
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00234208

Contacts
Contact: Martin A Brutsche, MD, PhD     +41612655194     mbrutsche@uhbs.ch    
Contact: Jan A Wiegand, MD     wiegandj@uhbs.ch    

Locations
Greece
Department of Pneumology, University Hospital of Alexandroupolis     Recruiting
      Alexandroupolis, Greece, 68100
      Contact: Marios E Froudarakis, MD, PhD         froudarm@uoc.gr    
      Principal Investigator: Marios E Froudarakis, MD, PhD            
Italy
Pulmonology Unit, Spedali Civili di Brescia     Recruiting
      Brescia, Italy, 25103
      Contact: Gian F Tassi, MD     +39 030 3995591     g.f.tassi@spedalicivili.brescia.it    
      Principal Investigator: Gian F Tassi, MD            
Pulmonology and Thoracic Endoscopy Unit Azienda Ospedaliera di Parma     Recruiting
      Parma, Italy, 43100
      Contact: Angelo G Casalini, MD     +39 0521 703416     angelocasalini@inwind.it    
      Principal Investigator: Angelo G Casalini, MD            
UO Pneumologia     Recruiting
      Imperia, Italy, 18100
      Contact: Marco Nosenzo, MD         m.nosenzo@asl1.liguria.it    
      Principal Investigator: Marco Nosenzo, MD            
Switzerland
University Hospital     Recruiting
      Basel, Switzerland, CH-4031
      Contact: Martin H Brutsche, MD, PhD     +41612655194     mbrutsche@uhbs.ch    
      Contact: Jan A Wiegand, MD         wiegandj@uhbs.ch    
      Sub-Investigator: Jan A Wiegand, MD            
      Principal Investigator: Martin H Brutsche, MD, PhD            
Centre Valaisan de Pneumologie     Not yet recruiting
      Crans-Montana, Switzerland, CH-3963
      Contact: Jean-Marie Tschopp, MD     + 41 27 603 81 80     jean-marie.tschopp@admin.vs.ch    
      Principal Investigator: Jean-Marie Tschopp, MD            

Sponsors and Collaborators
University Hospital, Basel, Switzerland
Lancardis foundation, Martigny Switzerland
Pfizer

Investigators
Principal Investigator:     Martin H Brutsche, MD, PhD     Pneumology, University Hospital of Basel    
  More Information


Study ID Numbers:   EK 186/05
First Received:   October 5, 2005
Last Updated:   April 24, 2007
ClinicalTrials.gov Identifier:   NCT00234208
Health Authority:   Switzerland: Laws and standards

Keywords provided by University Hospital, Basel, Switzerland:
Complicated parapneumonic effusion  
Pleural empyema  
Intervention  
Medical thoracoscopy  
Chest tube drainage  

Study placed in the following topic categories:
Empyema, Pleural
Respiratory Tract Diseases
Respiratory Tract Infections
Pleural Diseases
Suppuration
Empyema
Inflammation

Additional relevant MeSH terms:
Pathologic Processes
Infection

ClinicalTrials.gov processed this record on October 17, 2008




Links to all studies - primarily for crawlers